NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The bill was the first of a handful of proposals on the issue of transgender athletes to go to a floor vote in the Senate, where it was rejected 21-14.Read More
NBA Panic Meter Power Rankings: Which teams should be most concerned about the first roundApril 27, 2026